FDA
-
-
-
-
-
-
-
Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association
-
-
-
-
-
-
-
Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference
-
-
-
-
-
-
-
Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million
-
-
-
-
-
-
-
Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040
-
-
-
-
-
-
-
Cardiol locks database for phase II myocarditis trial
-
-
-
-
-
-
-
Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis
-
-
-
-
-
-
-
Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
-
326,554 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

